Erythropoietic Protoporphyria clinical trials at UCSF
3 in progress, 1 open to eligible people
Erythropoietic protoporphyria is a rare condition that causes skin pain when exposed to sunlight. UCSF is studying how a treatment called MT-7117 can help people with this condition spend more time in the sun without pain. This trial looks at how the treatment affects symptoms like burning and itching.
INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP
open to eligible people ages 12-75
To investigate the efficacy of MT-7117 on time to onset and severity of first prodromal symptoms (burning, tingling, itching, or stinging) associated with sunlight exposure in adults and adolescents with EPP or XLP.
San Francisco, California and other locations
Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
Sorry, not currently recruiting here
To evaluate the long-term safety and tolerability of oral dersimelagon.
San Francisco, California and other locations
Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants with EPP
Sorry, accepting new patients by invitation only
This is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in participants with EPP.
San Francisco, California and other locations
Last updated: